Cabiralizumab [1613144-80-1]

MedChem Express

Cabiralizumab [1613144-80-1]

10

1613144-80-1

Research Use Only

Monoclonal

99.73

Cabiralizumab (FPA 008) is an anti-CSF1R monoclonal antibody (MAb). Cabiralizumab enhances T cell infiltration and antitumor T cell immune responses. Cabiralizumab inhibits the activation of osteoclasts and blocks bone destruction, and can be used in the research of rheumatoid arthritis (RA). Cabiralizumab can combine with Nivolumab (HY-P9903) for lung cancer research[1][2][3][4].

-80°C

41116161